Facebook Linkedin RSS Twitter Youtube
Home 2016

Pfenex Expression Technology

Pfenex Eyes “Options” for Lucentis Biosimiar as Hospira Partnership Ends
Industry News

Pfenex Eyes “Options” for Lucentis Biosimiar as Hospira Partnership Ends

GEN Staff Writer -
0
Jazz Pharma to Develop Pfenex Blood Cancer Candidates
Industry News

Jazz Pharma to Develop Pfenex Blood Cancer Candidates

GEN Staff Writer -
0
Hospira Teaming Up with Pfenex to Commercialize Lucentis Biosimilar
Drug Discovery

Hospira Teaming Up with Pfenex to Commercialize Lucentis Biosimilar

GEN Staff Writer -
0
Pfenex and Agila Biotech Target Biosimilars
Drug Discovery

Pfenex and Agila Biotech Target Biosimilars

GEN Staff Writer -
0
Pfenex Division Begins Product Capacity Expansion
Bioprocessing

Pfenex Division Begins Product Capacity Expansion

GEN Staff Writer -
0
Needle-Free Anthrax Vaccine Wins NIAID Contract
Bioprocessing

Needle-Free Anthrax Vaccine Wins NIAID Contract

GEN Staff Writer -
0
Pfenex, DNA2.0 Ally to Improve Protein Expression Technology
Bioprocessing

Pfenex, DNA2.0 Ally to Improve Protein Expression Technology

GEN Staff Writer -
0
Pfenex to Supply Henry M. Jackson Foundation with Carrier Protein for Vaccine Development
Drug Discovery

Pfenex to Supply Henry M. Jackson Foundation with Carrier Protein for Vaccine Development

GEN Staff Writer -
0
Pfenex Scores Government Contract to Develop Production Process for Bulk Recombinant Protective Antigen from Anthrax
Bioprocessing

Pfenex Scores Government Contract to Develop Production Process for Bulk Recombinant Protective Antigen from Anthrax

GEN Staff Writer -
0
Rapid Identification of Production Strains
Bioprocessing

Rapid Identification of Production Strains

Sriram Kumaraswamy, Ph.D. -
0
12Page 1 of 2
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.